Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis

Identification of a Nuclear Receptor for Bile Acids

Makoto Makishima, Arthur Y. Okamoto, Joyce J. Repa et al. · Science · 1999 · 2.7K citations

Life Sciences, Genetics, Molecular Biology +17

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield, Ulrich Beuers, Christophe Corpechot et al. · Journal of Hepatology · 2017 · 1.5K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The cytoprotective role of the Keap1–Nrf2 pathway

Liam Baird, Albena T. Dinkova‐Kostova · Archives of Toxicology · 2011 · 1K citations

Life Sciences, Biochemistry, Molecular Biology +13

6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity

Roberto Pellicciari, Stefano Fiorucci, Emidio Camaioni et al. · Journal of Medicinal Chemistry · 2002 · 731 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12